Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06446661

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Conditions: Acute Lymphoblastic Leukemia

Sex: All
Ages: 15 Years – 39 Years
Healthy volunteers: No
Phase: NA
Enrollment: 38
Sponsor: University of Chicago

Location: University of Chicago Medicine Comprehensive Cancer Center Chicago Illinois

Summary

The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).

Eligibility Criteria

Inclusion Criteria: * Age of 15-39 years-old at the time of initial ALL diagnosis * Diagnosed with ALL * Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Exclusion Criteria: * Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages * Patient does not wish to participate * Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06446661). StuddyBuddy aggregates publicly available trial information.